Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Summary of publications:
Publications (original articles or review articles) published in 2015 from OUS - Experimental Immunotherapy (Olweus)
5 publications found
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
Gene Ther, 22 (5), 391-403
T-cell receptor gene therapy--ready to go viral?
Mol Oncol, 9 (10), 2019-42
High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
Hepatology, 63 (5), 1608-19
Unpredicted phenotypes of two mutants of the TcR DMF5
J Immunol Methods, 425, 37-44
Soluble T-cell receptors produced in human cells for targeted delivery
PLoS One, 10 (4), e0119559